Numero 2 - IPASVI - Roma

organico, quello psichico e quellocomportamentale. Gli adolescenti affettida T1DM non differiscono dai loro coetaneinon diabetici negli atteggiamenti enei comportamenti a rischio, nell’uso eabuso di alcool, di sostanze stupefacenti24 e con atteggiamenti di ribellioneper le convenzioni, situazioni classichedell’età giovanile.Nel passaggio da una MDI a una CSII, ilsenso di oppressione e vergogna chesovente accompagna le somministrazioniquotidiane di insulina, in molti casilontano da occhi indiscreti, tende a farespazio a una gestione autonoma e menoconflittuale 25 . Il giovane può riappropriarsidi una libertà che in molti contestisociali potrebbe venire meno ed èper questi motivi che molti giovani preferisconola CSII alla MDI.AUTORE:Anna Lisa Maviglia, Cpsi presso Ares 118Regione Lazio, AutoMedica “RomaEst”.BIBLIOGRAFIA1American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008 Jan;31 Suppl 1:S55-60.2Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ. 2006 Jul 18;175(2):165-70.3Rorsman P Insulin secretion: function and therapy of pancreatic beta-cells in diabetes British Journal of Diabetes & Vascular Disease 20055: 1874Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902‐12.5Sherry NA, Levitsky LL. Management of diabetic ketoacidosis in children and adolescents. Paediatr Drugs 2008;10:209‐15.6ISTAT. Istituto nazionale di statistica [disponibile su: www3.istat.it/dati/dataset/20080630_01/Tavole.xls Accesso: 16 agosto 2011]7Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P, Prisco F, Songini M, Tenconi MT, Cherubini V; RIDI StudyGroup. Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care. 2004 Dec;27(12):2790-6.8EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000 Mar 11;355(9207):873-6.9DCCT Research Group: The effect of intensive treatment of diabetes on development and progression of long term complications in insulindependent diabetes. New Engl J Med 329, 977-986, 199310Sherr J, Tamborlane WV. Past, present, and future of insulin pump therapy: better shot at diabetes control. Mt Sinai J Med. 2008Aug;75(4):352-61.11Lenhard MJ, Reeves GD Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001Oct 22;161(19):2293-300.12Wilson V. Experiences of parents of young people with diabetes using insulin pump therapy. Paediatric Nursing, 2008 Mar; 20 (2): 14-813Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severehypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care.1999 Nov;22(11):1779-84.14Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M. Comparison of continuous subcutaneousinsulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003Sep;112(3 Pt 1):559-64.15Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV. Persistence of benefits of continuous subcutaneousinsulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics. 2004 Dec;114(6):1601-5.16Wegner O, Wyka K, Fendler W, Zmysłowska A, Młynarski W Evaluation of preserved insulin secretion in children and adolescents with type1 diabetes Pediatr Endocrinol Diabetes Metab. 2010;16(2):67-71.17Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparisonwith conventional insulin therapy. Saudi Med J. 2005 Jun;26(6):918-22.18Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschoolchildren with type 1 diabetes mellitus. Diabetes Technol Ther. 2007 Aug;9(4):339-47.19Shalitin S, Phillip M. The use of insulin pump therapy in the pediatric age group. Horm Res. 2008;70(1):14-21. Epub 2008 May 21. Review.PMID:1849314520Pankowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections inchildren with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009 Feb;10(1):52-8.Epub 2008 Aug 2721NHS National Institute for Health and Clinical Exellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus.Review of technology appraisal guidance 57 July 2008 [disponibile su: http://www.nice.org.uk Accesso: 18 agosto 2011]22World Health Organization Therapeutic Patient Education Report of a WHO Working Group 1998 [Disponibile su: http://www.euro.who.intAccesso: 03/09/2011]23Young-Hyman DL, Davis CL. Disordered eating behavior in individuals with diabetes: importance of context, evaluation, and classification.Diabetes Care. 2010 Mar;33(3):683-9.24Frey MA, Guthrie B, Loveland-Cherry C, Park PS, Foster CM. Risky behavior and risk in adolescents with IDDM. J Adolesc Health. 1997Jan;20(1):38-45.25Comeaux SJ, Jaser SS. Autonomy and insulin in adolescents with type 1 diabetes. Pediatr Diabetes. 2010 Nov;11(7):498-504.8